GSE174743
GeoMx Cancer Transcriptome Atlas (CTA) mRNA assay on 191 ROIs from a NSCLC tumor.
Dense spatial gene expression profiling of a NSCLC tumor. This study was part of Danaher & Kim et al., "Advances in mixed cell deconvolution enable quantification of cell types in spatially resolved gene expression data" Overall design: Five NSCLC tumors were profiled with the GeoMx Cancer Transcriptome Atlas RNA assay. 20-24 ROIs were chosen from each tissue, and tumor (PanCK+) and microenvironment (PanCK-) AOIs were collected from each ROI. Matching GeoMx protein data was collected on the same tissues and ROIs.